Quinsair Treatment For Pseudomonas Aeruginosa in Adult CF Patients Picks Up Positive CHMP Opinion
Cystic Fibrosis, News
The Committee for Medicinal Products for Human Use (CHMP) recently announced a positive comment for the pharmaceutical compound Quinsair, a nebuliser solution administered in a 240 mg dose, based on ... Read more